232 related articles for article (PubMed ID: 14635317)
1. Factors associated with refractory renal disease in patients with systemic lupus erythematosus: the role of patient nonadherence.
Bruce IN; Gladman DD; Urowitz MB
Arthritis Care Res; 2000 Dec; 13(6):406-8. PubMed ID: 14635317
[TBL] [Abstract][Full Text] [Related]
2. The prognosis of biopsy-proven lupus nephritis in chinese patients: long term follow-up of 86 cases.
Shen K; Yu Y; Tang Z; Liu Z; Li L
Chin Med J (Engl); 1997 Jul; 110(7):502-7. PubMed ID: 9594205
[TBL] [Abstract][Full Text] [Related]
3. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.
Bruce IN; Hallett DC; Gladman DD; Urowitz MB
J Rheumatol; 1999 Jul; 26(7):1490-4. PubMed ID: 10405935
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
6. Clinical prognostic factors in lupus nephritis. The importance of hypertension and smoking.
Ward MM; Studenski S
Arch Intern Med; 1992 Oct; 152(10):2082-8. PubMed ID: 1417382
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and clinicopathologic findings of antiphospholipid syndrome nephropathy in Thai systemic lupus erythematosus patients who underwent renal biopsies.
Cheunsuchon B; Rungkaew P; Chawanasuntorapoj R; Pattaragarn A; Parichatikanond P
Nephrology (Carlton); 2007 Oct; 12(5):474-80. PubMed ID: 17803471
[TBL] [Abstract][Full Text] [Related]
8. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[TBL] [Abstract][Full Text] [Related]
9. Renal transplantation in patients with lupus nephritis: a single-center experience.
Ghafari A; Etemadi J; Ardalan MR
Transplant Proc; 2008; 40(1):143-4. PubMed ID: 18261571
[TBL] [Abstract][Full Text] [Related]
10. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
11. Association between serum total cholesterol level and renal outcome in systemic lupus erythematosus.
Tisseverasinghe A; Lim S; Greenwood C; Urowitz M; Gladman D; Fortin PR
Arthritis Rheum; 2006 Jul; 54(7):2211-9. PubMed ID: 16802357
[TBL] [Abstract][Full Text] [Related]
12. Adverse events and efficacy of TNF-alpha blockade with infliximab in patients with systemic lupus erythematosus: long-term follow-up of 13 patients.
Aringer M; Houssiau F; Gordon C; Graninger WB; Voll RE; Rath E; Steiner G; Smolen JS
Rheumatology (Oxford); 2009 Nov; 48(11):1451-4. PubMed ID: 19748965
[TBL] [Abstract][Full Text] [Related]
13. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
Pattaragarn A; Sumboonnanonda A; Parichatikanond P; Supavekin S; Suntornpoch V; Vongjirad A
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
[TBL] [Abstract][Full Text] [Related]
14. [Lupus nephritis in Senegal: study of 42 cases].
Dia D; Ka EF; Cissé M; Pouye A; Niang NM; Kane A; Dieng MT; Niang A; Ka MM; Diouf B; Ndiaye B; Moreira-Diop T
Dakar Med; 2007; 52(1):23-6. PubMed ID: 19102087
[TBL] [Abstract][Full Text] [Related]
15. Intentional and unintentional treatment nonadherence in patients with systemic lupus erythematosus.
Daleboudt GM; Broadbent E; McQueen F; Kaptein AA
Arthritis Care Res (Hoboken); 2011 Mar; 63(3):342-50. PubMed ID: 21120967
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in lupus nephritis: diagnostic and therapeutic delay increases the risk of terminal renal failure.
Faurschou M; Starklint H; Halberg P; Jacobsen S
J Rheumatol; 2006 Aug; 33(8):1563-9. PubMed ID: 16881113
[TBL] [Abstract][Full Text] [Related]
17. Natural history and treatment of lupus nephritis.
Austin HA; Balow JE
Semin Nephrol; 1999 Jan; 19(1):2-11. PubMed ID: 9952276
[TBL] [Abstract][Full Text] [Related]
18. The long-term outcome of 93 patients with proliferative lupus nephritis.
Moroni G; Quaglini S; Gallelli B; Banfi G; Messa P; Ponticelli C
Nephrol Dial Transplant; 2007 Sep; 22(9):2531-9. PubMed ID: 17510096
[TBL] [Abstract][Full Text] [Related]
19. Intravenous cyclophosphamide for lupus nephritis in Thai children.
Vachvanichsanong P; Dissaneewate P; Winn T
Scand J Rheumatol; 2004; 33(5):339-42. PubMed ID: 15513684
[TBL] [Abstract][Full Text] [Related]
20. Renal outcome and predictors of clinical renal involvement in patients with silent lupus nephritis.
Wada Y; Ito S; Ueno M; Nakano M; Arakawa M; Gejyo F
Nephron Clin Pract; 2004; 98(4):c105-11. PubMed ID: 15627787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]